AI-driven discovery platform fuses multi-omics data and machine learning to decode gut signatures, diagnose, and model microbiome–host interactions underlying Irritable Bowel Syndrome (IBS). Precision microbiome modulation therapy, augmented with custom CRISPR-like nucleases, targets root causes to restore gut balance and deliver lasting relief for IBS patients.